Comparison of the effect of ‘metabolically healthy but obese-and ‘metabolically abnormal but not obese-phenotypes on development of diabetes and cardiovascular disease in Chinese

详细信息    查看全文

• 作者：Deng Luo ; Fang Liu ; Xiaowen Li ; Dechao Yin ; Ziwei Lin ; Hui Liu ; Xuhong Hou…
• 关键词：Obesity ; Metabolic syndrome ; Diabetes ; CVD
• 刊名：Endocrine
• 出版年：2015
• 出版时间：May 2015
• 年：2015
• 卷：49
• 期：1
• 页码：130-138
• 全文大小：268 KB
• 参考文献：1.S. Frood, L.M. Johnston, C.L. Matteson, D.T. Finegood, Obesity, Complexity, and the Role of the Health System. Curr. Obes. Rep. 2, 320-26 (2013)View Article PubMed Central PubMed
  2.G. Reaven, F. Abbasi, T. McLaughlin, Obesity, insulin resistance, and cardiovascular disease. Recent Prog. Horm. Res. 59, 207-23 (2004)View Article PubMed
  3.E. Bonora, The metabolic syndrome and cardiovascular disease. Ann. Med. 38, 64-0 (2006)View Article PubMed
  4.N. Stefan, H.U. Haring, F.B. Hu, M.B. Schulze, Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 1, 152-62 (2013)View Article PubMed
  5.F. Conus, R. Rabasa-Lhoret, F. Peronnet, Characteristics of metabolically obese normal-weight (MONW) subjects. Appl. Physiol. Nutr. Metab. 32, 4-2 (2007)View Article PubMed
  6.A.D. Karelis, M. Brochu, R. Rabasa-Lhoret, Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 30, 569-72 (2004)View Article PubMed
  7.G.V. Denis, M.S. Obin, ‘Metabolically healthy obesity- origins and implications. Mol. Aspects Med. 34, 59-0 (2013)View Article PubMed Central PubMed
  8.M. Bluher, The distinction of metabolically ‘healthy-from ‘unhealthy-obese individuals. Curr. Opin. Lipidol. 21, 38-3 (2010)View Article PubMed
  9.C. Voulgari, N. Tentolouris, P. Dilaveris, D. Tousoulis, N. Katsilambros, C. Stefanadis, Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J. Am. Coll. Cardiol. 58, 1343-350 (2011)View Article PubMed
  10.S.H. Lee, H.S. Ha, Y.J. Park, J.H. Lee, H.W. Yim, K.H. Yoon, M.I. Kang, W.C. Lee, H.Y. Son, Y.M. Park, H.S. Kwon, Identifying metabolically obese but normal-weight (MONW) individuals in a nondiabetic Korean population: the Chungju Metabolic disease Cohort (CMC) study. Clin. Endocrinol. (Oxf) 75, 475-81 (2011)View Article
  11.J.B. Meigs, P.W. Wilson, C.S. Fox, R.S. Vasan, D.M. Nathan, L.M. Sullivan, R.B. D’Agostino, Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 91, 2906-912 (2006)View Article PubMed
  12.S. Camastra, E. Bonora, S. Del Prato, K. Rett, M. Weck, E. Ferrannini, Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int. J. Obes. Relat. Metab. Disord. 23, 1307-313 (1999)View Article PubMed
  13.E. Bonora, S. Kiechl, J. Willeit, F. Oberhollenzer, G. Egger, G. Targher, M. Alberiche, R.C. Bonadonna, M. Muggeo, Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47, 1643-649 (1998)View Article PubMed
  14.N. Ruderman, D. Chisholm, X. Pi-Sunyer, S. Schneider, The metabolically obese, normal-weight individual revisited. Diabetes 47, 699-13 (1998)View Article PubMed
  15.R.V. Dvorak, W.F. DeNino, P.A. Ades, E.T. Poehlman, Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 48, 2210-214 (1999)View Article PubMed
  16.F. Conus, D.B. Allison, R. Rabasa-Lhoret, M. St-Onge, D.H. St-Pierre, A. Tremblay-Lebeau, E.T. Poehlman, Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J. Clin. Endocrinol. Metab. 89, 5013-020 (2004)View Article PubMed
  17.W.H.O. Expert, Consultation, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157-63 (2004)View Article
  18.R.C. Ma, J.C. Chan, Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann. N. Y. Acad. Sci. 1281, 64-1 (2013)View Article PubMed Central PubMed
  19.L.L. Roberson, E.C. Aneni, W. Maziak, A. Agatston, T. Feldman, M. Rouseff, T. Tran, M.J. Blaha, R.D. Santos, A. Sposito, M.H. Al-Mallah, R. Blankstein, M.J. Budoff, K. Nasir, Beyond BMI: The “Metabolically healthy obese-phenotype and its association with clinical/subclinical cardiovascular disease and all-cause mortality -a systematic review. BMC Public Health 14, 14 (2014)View Article PubMed Central PubMed
  20.W.P. Jia, C. Pang, L. Chen, Y.Q. Bao, J.X. Lu, H.J. Lu, J.L. Tang, Y.M. Wu, Y.H. Zuo, S.Y. Jiang, K.S. Xiang, Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50, 286-92 (2007)View Article PubMed
  21.C. Wang, X.H. Hou, M.L. Zhang, Y.Q. Bao, Y.H. Zou, W.H. Zhong, K.S. Xiang, W.P. Jia, Comparison of body mass index with body fat percentage in the evaluation of obesity in Chinese. Biomed. Environ. Sci. 23, 173-79 (2010)View Article PubMed
  22.D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin re
• 作者单位：Deng Luo (1) (2) (3)
  Fang Liu (2) (3)
  Xiaowen Li (1) (2)
  Dechao Yin (1) (2)
  Ziwei Lin (1) (2) (3)
  Hui Liu (4)
  Xuhong Hou (1) (2)
  Chen Wang (1) (2) (3)
  Weiping Jia (1) (2) (3)
  
  1. Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, 600 Yishan Road, Shanghai, 200233, People’s Republic of China
  2. Shanghai Key Laboratory of Diabetes Mellitus, 600 Yishan Road, Shanghai, 200233, People’s Republic of China
  3. Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, 600 Yishan Road, Shanghai, 200233, People’s Republic of China
  4. Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China
  
• 刊物主题：Endocrinology; Diabetes; Internal Medicine; Science, general;
• 出版者：Springer US
• ISSN：1559-0100

文摘

The present study was designed to determine the prevalence of ‘metabolically healthy but obese-(MHO) and ‘metabolically abnormal but not obese-(MANO) phenotypes in Chinese population, and to investigate the association of these two phenotypes with the risk of diabetes and cardiovascular disease (CVD). A total of 2,764 subjects aged 30-0 were followed up over a mean period of 43.80?±?11.25?months. The metabolic syndrome was defined according to the joint committee for developing Chinese guidelines on prevention and treatment of dyslipidemia in adults. Subjects with body fat percentage (BF?%)?>25?% for men or BF?%?>35?% for women were defined as being obese. The proportion of MHO and MANO phenotypes were 22.9, 7.6?% in men, and 26.2, 6.0?% in women, respectively. The MANO phenotype was associated with increased risk for diabetes both in men [hazard?ratios (HR): 4.44 (1.21-6.26)] and women [HR: 8.68 (2.87-4.96)] after adjustment of age, serum total cholesterol (TC), triglycerides (TG), and family history of diabetes. This association held for CVD in women [HR: 2.87 (1.44-.73)], but not in men after adjustment of age, serum TC, TG, and family history of CVD. No association was observed between the MHO phenotype and incident diabetes or CVD. MHO and MANO phenotypes are common in Chinese population. Metabolic risk factors appeared to play a more important role in the development of diabetes and CVD than body fat alone.